BioCentury | Dec 19, 2019
Finance

Truffle’s recipe for company creation

...in Belgium, Switzerland and Germany. Pouletty himself is a serial entrepreneur, co-founding organ transplant company SangStat Medical Corp....
BioCentury | Apr 15, 2013
Company News

Sepragen board of directors update

...Appointed: Kris Venkat, chairman and CEO of Phyton Inc.; Henry Edmunds, VP and CFO at SangStat Medical Corp. WIR...
BioCentury | Jun 4, 2007
Finance

Ebb & Flow

...said he is familiar with PDLI from his days as chairman, president and CEO of Sangstat...
BioCentury | Apr 9, 2007
Strategy

Antibody polymath

...part of its 2003 acquisition of Sangstat Medical Corp. GENZ owns just under 20% of THP, which Sangstat...
BioCentury | Dec 19, 2005
Strategy

Abgenix chronicles

...well as profits.B. 3/4/99 - Raises $48.1M in a follow-on S. 2/18/03 - ABGX and SangStat...
BioCentury | Sep 15, 2004
Top Story

GENZ, Ilex acquisition delayed

...antithymocyte globulin antibody for transplant rejection. GENZ gained the product through its 2003 acquisition of SangStat...
BioCentury | Jul 26, 2004
Company News

Osel management update

...Santa Clara, Calif. Business: Infectious Hired: Ralph Levy as president, formerly SVP of Operations at SangStat Medical Corp. WIR...
BioCentury | Jun 28, 2004
Company News

Genelabs management update

...secretary Hired: Adrian Arima as VP and general counsel, formerly SVP and general counsel at SangStat Medical Corp....
BioCentury | Jun 7, 2004
Company News

Cellerant management update

...Gene/Cell therapy Hired: Timothy Fong as VP of research, formerly VP of discovery research at SangStat Medical Corp. WIR...
BioCentury | Apr 5, 2004
Company News

Genzyme, Procter & Gamble deal

...responsible for all future development in licensed indications. GENZ obtained RDP58 in its acquisition of SangStat Medical Corp....
Items per page:
1 - 10 of 340
BioCentury | Dec 19, 2019
Finance

Truffle’s recipe for company creation

...in Belgium, Switzerland and Germany. Pouletty himself is a serial entrepreneur, co-founding organ transplant company SangStat Medical Corp....
BioCentury | Apr 15, 2013
Company News

Sepragen board of directors update

...Appointed: Kris Venkat, chairman and CEO of Phyton Inc.; Henry Edmunds, VP and CFO at SangStat Medical Corp. WIR...
BioCentury | Jun 4, 2007
Finance

Ebb & Flow

...said he is familiar with PDLI from his days as chairman, president and CEO of Sangstat...
BioCentury | Apr 9, 2007
Strategy

Antibody polymath

...part of its 2003 acquisition of Sangstat Medical Corp. GENZ owns just under 20% of THP, which Sangstat...
BioCentury | Dec 19, 2005
Strategy

Abgenix chronicles

...well as profits.B. 3/4/99 - Raises $48.1M in a follow-on S. 2/18/03 - ABGX and SangStat...
BioCentury | Sep 15, 2004
Top Story

GENZ, Ilex acquisition delayed

...antithymocyte globulin antibody for transplant rejection. GENZ gained the product through its 2003 acquisition of SangStat...
BioCentury | Jul 26, 2004
Company News

Osel management update

...Santa Clara, Calif. Business: Infectious Hired: Ralph Levy as president, formerly SVP of Operations at SangStat Medical Corp. WIR...
BioCentury | Jun 28, 2004
Company News

Genelabs management update

...secretary Hired: Adrian Arima as VP and general counsel, formerly SVP and general counsel at SangStat Medical Corp....
BioCentury | Jun 7, 2004
Company News

Cellerant management update

...Gene/Cell therapy Hired: Timothy Fong as VP of research, formerly VP of discovery research at SangStat Medical Corp. WIR...
BioCentury | Apr 5, 2004
Company News

Genzyme, Procter & Gamble deal

...responsible for all future development in licensed indications. GENZ obtained RDP58 in its acquisition of SangStat Medical Corp....
Items per page:
1 - 10 of 340